Sarcoidosis Drugs Market, by Type (Pulmonary Sarcoidosis, Ocular Sarcoidosis, Neurosarcoidosis, Cardiac Sarcoidosis, Musculoskeletal Sarcoidosis, Cutaneous Sarcoidosis, Renal Sarcoidosis, Hepatic Sarcoidosis, Sarcoidosis of the Spleen and Bone Marrow), by Mechanism of Action (Corticosteroid, Immunosuppressants, Antimalarial, Tumor Necrosis Factor-alpha (TNF-Alpha) Inhibitors), by Drug Type (Corticotropin, Chloroquine, Dexamethasone, Colchicine, Prednisone, Methotrexate, Hydroxychloroquine, Azathioprine, Deltasone) and, by End User (Hospitals Clinics, Surgical Centers, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032